NASDAQ: NBP
Novabridge Biosciences Stock Ownership - Who owns Novabridge Biosciences?

Insider buying vs selling

Have Novabridge Biosciences insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when NBP insiders and whales buy or sell their stock.

NBP Shareholders

What type of owners hold Novabridge Biosciences stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Janus Henderson Group PLC3.01%7,991,377$33.48MInstitution
Hhlr Advisors Ltd2.26%5,980,568$25.06MInstitution
Adage Capital Partners GP LLC1.26%3,338,034$13.99MInstitution
Morgan Stanley0.84%2,232,040$9.35MInstitution
Ariose Capital Management Ltd0.64%1,704,393$7.14MInstitution
Exome Asset Management LLC0.54%1,439,604$6.03MInstitution
Siren LLC0.44%1,165,957$4.89MInstitution
Candriam Sca0.43%1,132,563$4.75MInstitution
Woodline Partners LP0.40%1,050,000$4.40MInstitution
Point72 Hong Kong Ltd0.21%561,366$2.35MInstitution

1 of 3

NBP vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NBP11.20%0.00%
BCYC53.20%43.20%Net SellingNet Selling
DNA9.27%90.73%Net SellingNet Selling
PRTA49.89%50.11%Net Selling
FDMT69.20%22.28%Net BuyingNet Buying

Novabridge Biosciences Stock Ownership FAQ

Who owns Novabridge Biosciences?

Novabridge Biosciences (NASDAQ: NBP) is owned by 11.20% institutional shareholders, 0.00% Novabridge Biosciences insiders, and 88.80% retail investors. Janus Henderson Group PLC is the largest individual Novabridge Biosciences shareholder, owning 7.99M shares representing 3.01% of the company. Janus Henderson Group PLC's Novabridge Biosciences shares are currently valued at $33.48M.

If you're new to stock investing, here's how to buy Novabridge Biosciences stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.